Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06158581 · ClinicalTrials.gov registry record · NA
Comparing Two Different Emotion Therapies for Autistic Youth and Young Adults
A NA study of Autism Spectrum Disorder, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- NA
- Development phase
- 470
- Enrollment target
- 2
- Study locations
NCT06158581: Recruiting NA study of Autism Spectrum Disorder, sponsored by University of Pittsburgh.
NCT06158581 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 470 participants, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (253% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06158581, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- NA
- Development phase
- 470 participants
- Enrollment target
- 2
- Study locations
Study Summary
Too few clinicians are able and willing to help autistic patients. A recent review identified challenges to mental health service delivery in autism, including a lack of interventions designed for community implementation and limited workforce capacity. It has been argued that improving impairment in emotion regulation has the potential to improve a range of mental health difficulties in autistic people. In this clinical trial, the investigators are comparing two evidence-based interventions for emotion regulation, to determine if one created specifically for autistic people is clinically superior. The interventions will be implemented in the community, through partnering agencies.
Primary Outcome
The EDI does not have a single overall score. It is comprised of two scales: Reactivity and Dysphoria. Items are on a 0 to 4 scale, where 0 is Never happens and 4 is Almost always happens or causes a serious problem. There are clinical cutoffs for both scales.
Conditions Studied
Interventions
- BEHAVIORAL The Emotion Awareness and Skills Enhancement Program
- BEHAVIORAL The Unified Protocol
Study Locations (2)
Alabama
- University of Alabama - Tuscaloosa
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 470 participants |
| Start Date | 2024-04-08 |
| Est. Completion | 2027-08-01 |
| Phase | NA |
What NCT06158581 shows while recruiting
NCT06158581 is an interventional study that assigns participants to a tested intervention. The registered 470 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (253% higher).
The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which The Emotion Awareness and Skills Enhancement Program is the first listed.
NCT06158581 reports a single indexed study location in Alabama, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06158581 about?
NCT06158581 is a clinical study titled "Comparing Two Different Emotion Therapies for Autistic Youth and Young Adults". Too few clinicians are able and willing to help autistic patients. A recent review identified challenges to mental health service delivery in autism, including a lack of interventions designed for community implementation and limited workforce capacity. It has been argued that improving impairment i...
What is the current status of trial NCT06158581?
This trial is currently recruiting. It is a NA study. The enrollment target is 470 participants. The study started on 2024-04-08. Estimated completion is 2027-08-01.
What conditions does trial NCT06158581 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder.
What interventions are being tested in trial NCT06158581?
The interventions under investigation include: The Emotion Awareness and Skills Enhancement Program (BEHAVIORAL), The Unified Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT06158581?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06158581 being conducted?
This trial has 2 study locations across Alabama, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06158581's enrollment target sits among peer trials
470 15th of 224 higher than 210 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05256940 · 470 participants · NA
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide
- NCT05458219 · 470 participants · Phase 1
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
- NCT05850689 · 470 participants · Phase 3
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
- NCT05935384 · 470 participants
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI